Mikkel Østergaard
Impact in
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Osteoarthritis Treatment and Mechanisms
- Rehabilitation top 0.5%
- Musculoskeletal Disorders and Rehabilitation
Papers in
- Rheumatology 581
- Rheumatoid Arthritis Research and Therapies 345
- Spondyloarthritis Studies and Treatments 240
- Osteoarthritis Treatment and Mechanisms 20
-
- Musculoskeletal Disorders and Rehabilitation 10
- Co-authors
- Susanne Juhl Pedersen (90 shared papers)Merete Lund Hetland (124 shared papers)Marcin Szkudlarek (20 shared papers)Philip Conaghan (89 shared papers)Robert George William Lambert (50 shared papers)Bo Ejbjerg (40 shared papers)Walter P. Maksymowych (65 shared papers)Mette Klarlund (20 shared papers)
- Journals
- Annals of the Rheumatic Diseases (120 papers)The Journal of Rheumatology (81 papers)Lara D. Veeken (56 papers)Arthritis Research & Therapy (38 papers)Scandinavian Journal of Rheumatology (29 papers)
- Partner nations
- DenmarkUnited KingdomNorway
In The Last Decade
Mikkel Østergaard
605 papers receiving 24.6k citations
Mikkel Østergaard's Hit Papers
Peers
Comparison fields: 5 of 138
- Rheumatology 21k
- Rehabilitation 440
- Critical Care and Intensive Care Medicine 283
- Nephrology 507
- Radiology, Nuclear Medicine and Imaging 873
Countries citing papers authored by Mikkel Østergaard
This map shows the geographic impact of Mikkel Østergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikkel Østergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikkel Østergaard more than expected).
Fields of papers citing papers by Mikkel Østergaard
This network shows the impact of papers produced by Mikkel Østergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikkel Østergaard. The network helps show where Mikkel Østergaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Mikkel Østergaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 634 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force Hit paper breakdown → | 2015 | 1165 |
| 2 | Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group Hit paper breakdown → | 2009 | 718 |
| 3 | OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. Hit paper breakdown → | 2003 | 647 |
| 4 | Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis Hit paper breakdown → | 2003 | 602 |
| 5 | EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis Hit paper breakdown → | 2013 | 525 |
| 6 | Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry Hit paper breakdown → | 2009 | 470 |
| 7 | Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group Hit paper breakdown → | 2016 | 441 |
| 8 | EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice Hit paper breakdown → | 2015 | 434 |
| 9 | 2008 | 411 | |
| 10 | 2004 | 336 | |
| 11 | Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study Hit paper breakdown → | 2018 | 318 |
| 12 | 2008 | 294 | |
| 13 | 2010 | 271 | |
| 14 | MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group Hit paper breakdown → | 2019 | 243 |
| 15 | 2005 | 242 | |
| 16 | 1997 | 220 | |
| 17 | 2006 | 218 | |
| 18 | 2012 | 212 | |
| 19 | 2010 | 209 | |
| 20 | 2013 | 209 |
About Mikkel Østergaard
Mikkel Østergaard is a scholar working on Rheumatology, Rehabilitation, Nephrology, Physiology and Pharmacology, having authored 634 papers that have together received 25.6k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (345 papers), Spondyloarthritis Studies and Treatments (240 papers), Osteoarthritis Treatment and Mechanisms (20 papers), Musculoskeletal Disorders and Rehabilitation (10 papers), Orthopedic Surgery and Rehabilitation (9 papers), Gout, Hyperuricemia, Uric Acid (8 papers), Sleep and related disorders (7 papers) and Musculoskeletal pain and rehabilitation (6 papers). The work is most often cited by research in Rheumatology (21k citations), Rehabilitation (440 citations), Critical Care and Intensive Care Medicine (283 citations), Nephrology (507 citations) and Radiology, Nuclear Medicine and Imaging (873 citations). Mikkel Østergaard has collaborated with scholars based in Denmark, United Kingdom and Norway. Frequent co-authors include Susanne Juhl Pedersen, Merete Lund Hetland, Marcin Szkudlarek, Philip Conaghan, Robert George William Lambert, Bo Ejbjerg, Walter P. Maksymowych, Mette Klarlund, Paul E. Emery and Henrik S. Thomsen. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology, Lara D. Veeken, Arthritis Research & Therapy and Scandinavian Journal of Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.